Adding trabectedin to treatment with doxorubicin improved progression-free and overall survival in patients with advanced leiomyosarcoma.

Investigators in Japan evaluated 1 week of oral naldemedine for treatment of opioid-induced constipation in cancer patients receiving palliative care in a real-world setting.

HealthDay News — For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of life compared with conventional fractionation (CF), with ...

The 5-year disease-free survival rate was 84% in patients who received androgen deprivation therapy in combination with radiotherapy and 76% in patients who received radiotherapy alone. Combining ...

A total of 73 drug-drug interactions (DDIs) were detected, leading to discontinuation, therapeutic monitoring, oral anticancer therapy (OAT) change, OAT optimization, and/or dose adjustment.

The hormone sensitivity of breast tissue makes it even more susceptible to damage from ionizing radiation from imaging ...

The Food and Drug Administration (FDA) has granted traditional approval to Retevmo ® (selpercatinib) for adult and pediatric patients 2 years and older with advanced or metastatic medullary thyroid ...

Researchers sought to determine whether CAR-T therapy would be effective in patients with RRMM and light chain amyloidosis.

Adding upfront stereotactic radiosurgery to treatment with CNS-penetrant TKIs can improve some outcomes in patients with NSCLC and brain metastasis, a study suggests.

Bintrafusp alfa has demonstrated activity in a phase 2 trial of patients with recurrent or metastatic cervical cancer.

Melanoma incidence highest on trunk in men; incidence historically highest on limbs in women, but recent increases seen in truncal melanoma.